Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $10.3 million.

  • Healthequity's Capital Expenditures fell 1803.36% to $10.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $50.0 million, marking a year-over-year increase of 285.33%. This contributed to the annual value of $51.1 million for FY2025, which is 2433.19% up from last year.
  • According to the latest figures from Q4 2025, Healthequity's Capital Expenditures is $10.3 million, which was down 1803.36% from $10.4 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Capital Expenditures registered a high of $16.9 million during Q4 2021, and its lowest value of $9.0 million during Q2 2023.
  • Moreover, its 5-year median value for Capital Expenditures was $12.4 million (2024), whereas its average is $12.6 million.
  • Its Capital Expenditures has fluctuated over the past 5 years, first surged by 6929.47% in 2021, then crashed by 3637.24% in 2022.
  • Quarter analysis of 5 years shows Healthequity's Capital Expenditures stood at $16.9 million in 2021, then crashed by 34.51% to $11.1 million in 2022, then rose by 4.76% to $11.6 million in 2023, then grew by 8.19% to $12.6 million in 2024, then decreased by 18.03% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q4 2025, $10.4 million for Q3 2025, and $16.1 million during Q2 2025.